Search Results

There are 7407082 results for: content related to: Assessment of JC virus DNA in blood and urine from natalizumab-treated patients

  1. Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy

    Annals of Neurology

    Volume 76, Issue 6, December 2014, Pages: 792–801, Clemens Warnke, Gloria von Geldern, Philipp Markwerth, Thomas Dehmel, Robert Hoepner, Ralf Gold, Michael Pawlita, Tania Kümpfel, Mathias Mäurer, Martin Stangel, Florian Wegner, Reinhard Hohlfeld, Vera Straeten, Volker Limmroth, Thomas Weber, Derik Hermsen, Christoph Kleinschnitz, Hans-Peter Hartung, Mike P. Wattjes, Anders Svenningson, Eugene Major, Tomas Olsson, Bernd C. Kieseier and Ortwin Adams

    Version of Record online : 8 MAY 2014, DOI: 10.1002/ana.24153

  2. Assessment of JC virus DNA in blood and urine from natalizumab-treated patients

    Annals of Neurology

    Volume 68, Issue 3, September 2010, Pages: 304–310, Richard A. Rudick, Paul W. O'Connor, Chris H. Polman, Andrew D. Goodman, Soma S. Ray, Nancy M. Griffith, Stephanie A. Jurgensen, Leonid Gorelik, Fiona Forrestal, Alfred W. Sandrock and Susan E. Goelz

    Version of Record online : 24 AUG 2010, DOI: 10.1002/ana.22107

  3. JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis

    Annals of Neurology

    Volume 75, Issue 6, June 2014, Pages: 925–934, Spyridon Chalkias, Xin Dang, Evelyn Bord, Marion C. Stein, R. Philip Kinkel, Jacob A. Sloane, Maureen Donnelly, Carolina Ionete, Maria K. Houtchens, Guy J. Buckle, Stephanie Batson and Igor J. Koralnik

    Version of Record online : 10 JUN 2014, DOI: 10.1002/ana.24148

  4. Immune surveillance in multiple sclerosis patients treated with natalizumab

    Annals of Neurology

    Volume 59, Issue 5, May 2006, Pages: 743–747, Olaf Stüve, Christina M. Marra, Keith R. Jerome, Linda Cook, Petra D. Cravens, Sabine Cepok, Elliot M. Frohman, J. Theodore Phillips, Gabriele Arendt, Bernhard Hemmer, Nancy L. Monson and Michael K. Racke

    Version of Record online : 21 APR 2006, DOI: 10.1002/ana.20858

  5. You have full text access to this OnlineOpen article
    Anti–JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy

    Annals of Neurology

    Volume 76, Issue 6, December 2014, Pages: 802–812, Tatiana Plavina, Meena Subramanyam, Gary Bloomgren, Sandra Richman, Amy Pace, Sophia Lee, Brian Schlain, Denise Campagnolo, Shibeshih Belachew and Barry Ticho

    Version of Record online : 24 OCT 2014, DOI: 10.1002/ana.24286

  6. Study of the anti-JCV antibody levels in a Spanish multiple sclerosis cohort

    European Journal of Clinical Investigation

    Volume 47, Issue 2, February 2017, Pages: 158–166, María I. Dominguez-Mozo, Macarena Rus, Jose L. Santiago, Guillermo Izquierdo, Ignacio Casanova, Victoria Galan, M. Angel Garcia-Martinez, Ana M. Arias-Leal, Marta García-Montojo, Silvia Pérez-Pérez, Rafael Arroyo and Roberto Alvarez-Lafuente

    Version of Record online : 28 JAN 2017, DOI: 10.1111/eci.12721

  7. Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years

    European Journal of Neurology

    Volume 23, Issue 6, June 2016, Pages: 1101–1109, R. Zivadinov, D. Hojnacki, N. Bergsland, C. Kennedy, J. Hagemeier, R. Melia, D. P. Ramasamy, J. Durfee, E. Carl, M. G. Dwyer and B. Weinstock-Guttman

    Version of Record online : 21 MAR 2016, DOI: 10.1111/ene.12992

  8. Monitoring the John Cunningham virus throughout natalizumab treatment in multiple sclerosis patients

    European Journal of Neurology

    Volume 23, Issue 1, January 2016, Pages: 182–189, M. I. Domínguez-Mozo, M. García-Montojo, A. Arias-Leal, Á. García-Martínez, J. L. Santiago, I. Casanova, V. Galán, R. Arroyo, M. Fernández-Arquero and R. Alvarez-Lafuente

    Version of Record online : 25 OCT 2015, DOI: 10.1111/ene.12834

  9. You have free access to this content
    Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis

    European Journal of Immunology

    Volume 42, Issue 3, March 2012, Pages: 790–798, Raquel Planas, Ilijas Jelc̆ić, Sven Schippling, Roland Martin and Mireia Sospedra

    Version of Record online : 27 DEC 2011, DOI: 10.1002/eji.201142108

  10. You have free access to this content
    Requirement for safety monitoring for approved multiple sclerosis therapies: an overview

    Clinical & Experimental Immunology

    Volume 175, Issue 3, March 2014, Pages: 397–407, P. S. Rommer, U. K. Zettl, B. Kieseier, H.-P. Hartung, T. Menge, E. Frohman, B. M. Greenberg, B. Hemmer and O. Stüve

    Version of Record online : 4 FEB 2014, DOI: 10.1111/cei.12206

  11. You have free access to this content
    Pharmacological Properties, Toxicology and Scientific Rationale for the use of Natalizumab (Tysabri®) in Inflammatory Diseases

    CNS Drug Reviews

    Volume 13, Issue 1, March 2007, Pages: 79–95, Olaf Stüve and Jeffrey L. Bennett

    Version of Record online : 24 APR 2007, DOI: 10.1111/j.1527-3458.2007.00003.x

  12. Natalizumab for induction of remission in Crohn's disease

    Intervention Review

    The Cochrane Library

    John K MacDonald and John WD McDonald

    Published Online : 24 JAN 2007, DOI: 10.1002/14651858.CD006097.pub2

  13. You have full text access to this OnlineOpen article
    Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b

    Annals of Clinical and Translational Neurology

    Volume 2, Issue 1, January 2015, Pages: 43–55, Jens Ingwersen, Til Menge, Britta Wingerath, Derya Kaya, Jonas Graf, Tim Prozorovski, Andreas Keller, Christina Backes, Markus Beier, Matthias Scheffler, Thomas Dehmel, Bernd C. Kieseier, Hans-Peter Hartung, Patrick Küry and Orhan Aktas

    Version of Record online : 5 DEC 2014, DOI: 10.1002/acn3.152

  14. You have full text access to this OnlineOpen article
    Comparative efficacy of switching to natalizumab in active multiple sclerosis

    Annals of Clinical and Translational Neurology

    Volume 2, Issue 4, April 2015, Pages: 373–387, Timothy Spelman, Tomas Kalincik, Annie Zhang, Fabio Pellegrini, Heinz Wiendl, Ludwig Kappos, Larisa Tsvetkova, Shibeshih Belachew, Robert Hyde, Freek Verheul, Francois Grand-Maison, Guillermo Izquierdo, Pierre Grammond, Pierre Duquette, Alessandra Lugaresi, Jeannette Lechner-Scott, Celia Oreja-Guevara, Raymond Hupperts, Thor Petersen, Michael Barnett, Maria Trojano, Helmut Butzkueven and on behalf of the MSBase Investigators and the TOP investigators

    Version of Record online : 27 FEB 2015, DOI: 10.1002/acn3.180

  15. You have full text access to this OnlineOpen article
    Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon-β therapy

    European Journal of Neurology

    Volume 21, Issue 3, March 2014, Pages: 377–e20, M. S. Freedman

    Version of Record online : 15 NOV 2013, DOI: 10.1111/ene.12299

  16. High cumulative JC virus seroconversion rate during long-term use of natalizumab

    European Journal of Neurology

    Volume 23, Issue 6, June 2016, Pages: 1079–1085, A. Vennegoor, J. A. van Rossum, C. Leurs, M. P. Wattjes, T. Rispens, J. L. A. N. Murk, B. M. J. Uitdehaag and J. Killestein

    Version of Record online : 27 MAR 2016, DOI: 10.1111/ene.12988

  17. Persistence and pathogenesis of the neurotropic polyomavirus JC

    Annals of Neurology

    Volume 77, Issue 4, April 2015, Pages: 560–570, Hassen S. Wollebo, Martyn K. White, Jennifer Gordon, Joseph R. Berger and Kamel Khalili

    Version of Record online : 6 MAR 2015, DOI: 10.1002/ana.24371

  18. Finger pointing to JC virus: A tale of two indexes

    Annals of Neurology

    Volume 76, Issue 6, December 2014, Pages: 789–791, Igor J. Koralnik

    Version of Record online : 17 NOV 2014, DOI: 10.1002/ana.24302

  19. You have free access to this content
    Molecular targeted therapy against the blood–brain barrier in multiple sclerosis

    Clinical and Experimental Neuroimmunology

    Volume 5, Issue s1, December 2014, Pages: 28–34, Takashi Kanda

    Version of Record online : 18 DEC 2014, DOI: 10.1111/cen3.12167

  20. Anti-JC virus antibodies: Implications for PML Risk Stratification

    Annals of Neurology

    Volume 68, Issue 3, September 2010, Pages: 295–303, Leonid Gorelik, Michaela Lerner, Sarah Bixler, Mary Crossman, Brian Schlain, Kenneth Simon, Amy Pace, Anne Cheung, Ling Ling Chen, Melissa Berman, Fairuz Zein, Ewa Wilson, Ted Yednock, Alfred Sandrock, Susan E. Goelz and Meena Subramanyam

    Version of Record online : 24 AUG 2010, DOI: 10.1002/ana.22128